Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Other financing activities (2016 - 2025)

American Healthcare REIT (AHR) has disclosed Other financing activities for 11 consecutive years, with $9.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 219.5% year-over-year to $9.8 million, compared with a TTM value of $10.1 million through Dec 2025, up 47790.48%, and an annual FY2025 reading of $10.1 million, up 47790.48% over the prior year.
  • Other financing activities was $9.8 million for Q4 2025 at American Healthcare REIT, up from -$2.1 million in the prior quarter.
  • Across five years, Other financing activities topped out at $9.8 million in Q4 2025 and bottomed at -$8.2 million in Q4 2024.
  • Average Other financing activities over 5 years is $682950.0, with a median of $951500.0 recorded in 2023.
  • Peak annual rise in Other financing activities hit 2314.71% in 2022, while the deepest fall reached 405.24% in 2022.
  • Year by year, Other financing activities stood at -$2.4 million in 2021, then surged by 158.0% to $1.4 million in 2022, then tumbled by 236.18% to -$1.9 million in 2023, then plummeted by 324.6% to -$8.2 million in 2024, then skyrocketed by 219.5% to $9.8 million in 2025.
  • Business Quant data shows Other financing activities for AHR at $9.8 million in Q4 2025, -$2.1 million in Q3 2025, and $2.1 million in Q2 2025.